Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 7Phase 1/2 4Phase 3 3Phase 4 1Phase 2/3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Melanoma 18Carcinoma, Non-Small-Cell Lung 10Carcinoma, Renal Cell 9Kidney Neoplasms 4Stomach Neoplasms 3Mesothelioma 3Lung Neoplasms 3Diabetes Mellitus, Insulin-Dependent, 12 3Carcinoma, Hepatocellular 3Skin Neoplasms 2Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Various Advanced Cancer 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Non-Small Cell Lung Cancer Metastatic 1Neoplasms 1Melanoma, Cutaneous Malignant 1Lymphatic Metastasis 1

Interventions

Carboplatin 67Cisplatin 57Paclitaxel 42Radiotherapy 35Pemetrexed 34Gemcitabine 31Docetaxel 31Etoposide 25pembrolizumab 21Vinorelbine 20Erlotinib Hydrochloride 13Magnetic Resonance Spectroscopy 12Gefitinib 11Specimen Handling 10Radiosurgery 10Drug Therapy 10Bevacizumab 10durvalumab 9Nivolumab 9Vinblastine 6Topotecan 6Surgical Procedures, Operative 6Cyclophosphamide 6atezolizumab 5Standard of Care 5Platinum 5Immunoglobulin G 5Ifosfamide 5Disulfides 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Lung Neoplasms × Ipilimumab × Clear all
NCT03391869 2026-03-23

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
339 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02538666 2023-01-05

CheckMate 451

Bristol-Myers Squibb

Phase 3 Completed
907 enrolled 17 charts
Thoracic

Lung Neoplasms

NCT02279732 2019-08-28

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin

Bristol-Myers Squibb

Phase 3 Completed
342 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡